Application

16094098 · DEGRADATION OF CYCLIN-DEPENDENT KINASE 4/6 (CDK4/6) BY CONJUGATION OF CDK4/6 INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE

Filed 2018-10-16 · Granted · Patent 10865204 (2020-12-15) The official file ↗The patent and its PDF ↗ · Art unit 1624 · Examiner Bruck Kifle Easy · CPC C07D 471/04 · Dana-Farber Cancer Institute, Inc. · ArentFox Schiff, LLP & DFCI

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

9.5 mo

to disposition 26.0 mo

Statutes raised

112

2 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.